Stock MYL MYLAN N.V.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Mylan N.V. Nasdaq

Equities

MYL

NL0011031208

Chart calendar Mylan N.V.

b8a32b935fbadae208.8Xefk58Y3gkOfhVwZZFEd9aq3sfgHj9kasqfQzKEiR0.tgTM_6hrqTlFKl8IVbwiGeXIhqSHaFZXAYj9KGvc2zCyB9TqxWGLZGYQWA~a6a9b3f9ab4cf61fcb77f068476292c1

Upcoming events on Mylan N.V.

2024-05-08 Q1 2024 Earnings Release Pre-market
2024-05-09 08:30 am Q1 2024 Earnings Call
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)
2025-05-11 Q1 2025 Earnings Release (Projected)

Past events on Mylan N.V.

2024-03-27 10:00 am R&D Day
2024-03-07 Ex-dividend day
2024-02-28 08:30 am Q4 2023 Earnings Call
2024-02-28 06:30 am Q4 2023 Earnings Release
2024-01-10 01:30 pm JPMorgan Healthcare Conference
2023-12-15 11:00 am Annual General Meeting
2023-11-21 Ex-dividend day
2023-11-15 04:30 am Jefferies London Healthcare Conference
2023-11-07 05:00 pm Q3 2023 Earnings Call
2023-11-07 04:02 pm Q3 2023 Earnings Release
2023-08-22 Ex-dividend day
2023-08-07 08:30 am Q2 2023 Earnings Call
2023-08-07 06:59 am Q2 2023 Earnings Release
2023-06-13 04:20 pm Goldman Sachs Global Healthcare Conference
2023-05-22 Ex-dividend day
2023-05-08 08:30 am Q1 2023 Earnings Call
2023-05-08 06:59 am Q1 2023 Earnings Release
2023-04-24 05:30 pm American Academy of Neurology Meeting - Poster #014
2023-03-07 Ex-dividend day
2023-02-27 08:30 am Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		11 501
11 537
-0.32%		11 946
12 273
-2.66%		17 886
17 881
0.03%		16 263
16 372
-0.67%		15 427
15 465
-0.25%
15 219

EBITDA
Million USD		Released
Forecast
Spread 		3 540
3 500
1.12%		3 654
4 483
-18.49%		6 426
6 464
-0.59%		5 777
5 852
-1.29%		5 124
5 197
-1.4%
4 885

EBIT
Million USD		Released
Forecast
Spread 		3 264
3 212
1.62%		3 376
3 864
-12.61%		6 046
6 111
-1.07%		5 475
5 566
-1.62%		4 725
4 851
-2.6%
4 570

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		154
807
-80.87%		-721
3 677
-119.61%		-664
-580
-14.55%		2 813
878
220.41%		203
1 198
-83.06%
4 100

Net income
Million USD		Released
Forecast
Spread 		16,8
427
-96.07%		-670
1 449
-146.24%		-1 269
-952
-33.29%		2 079
1 328
56.46%		54,7
812
-93.26%
1 885

EPS
USD		Released
Forecast
Spread 		0,03
0,81
-96.3%		-1,11
1,62
-168.59%		-1,05
-0,77
-36.36%		1,71
1,01
69.62%		0,05
0,84
-94.02%
1,45

Announcement Date27/02/2001/03/2128/02/2227/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		4 342
4 337
0.11%		4 192
4 258
-1.55%		4 117
4 185
-1.62%		4 078
4 136
-1.39%		3 876
3 988
-2.8%		3 729
3 812
-2.18%		3 919
3 862
1.45%		3 942
3 997
-1.37%		3 837
3 877
-1.03%
3 707


3 830


3 908


3 896


3 821

EBITDA
Million USD		Released
Forecast
Spread 		1 416
1 481
-4.39%		1 586
1 445
9.8%		1 482
1 443
2.73%		1 498
1 431
4.69%		1 211
1 288
-6%		1 341
1 222
9.69%		1 306
1 255
4.04%		1 360
1 293
5.2%		1 117
1 220
-8.44%
1 247


1 188


1 258


1 195




EBIT
Million USD		Released
Forecast
Spread 		1 314
1 383
-5.04%		1 551
1 375
12.82%		1 425
1 375
3.57%		1 415
1 368
3.4%		1 085
1 166
-6.96%		1 255
1 151
9.02%		1 226
1 178
4.12%		1 257
1 208
4.05%		987
1 100
-10.29%
1 101


1 139


1 191


1 125


1 131

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-204
-119
-71.34%		528
48,0
998.96%














402
260
54.69%		-855
140
-710.71%














Net income
Million USD		Released
Forecast
Spread 		-264
53,2
-595.86%		399
149
167.56%		314
234
34.21%		354
357
-0.78%		1 011
257
292.86%		225
154
46.31%		264
225
17.13%		332
246
35.03%		-766
114
-771.58%
123


144


188


188




EPS
USD		Released
Forecast
Spread 		-0,22
0,41
-154.32%		0,33
0,08
304.11%		0,26
0,19
36.43%		0,29
0,42
-31.07%		0,83
0,15
453%		0,19
0,23
-15.82%		0,22
0,20
8.2%		0,27
0,34
-20.08%		-0,64
0,26
-344.8%
0,12


0,14


0,23


0,30




Announcement Date28/02/2209/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2328/02/24-----

Upcoming sector events for Mylan N.V.

2024-04-24 HIKMA PHARMACEUTICALS PLC: Q1 2024 Sales and Revenue Release - Trading Update
2024-04-24 IPSEN: Q1 2024 Sales and Revenue Release
2024-04-24 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q4 2023 Earnings Release
2024-04-24 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD: Q1 2024 Earnings Release
2024-04-24 HUNAN JIUDIAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-24 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-24 OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 LAURUS LABS LIMITED: Q4 2024 Earnings Release
2024-04-24 PT KALBE FARMA TBK.: Q1 2024 Earnings Release (Projected)
2024-04-24 GLENMARK LIFE SCIENCES LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Mylan N.V.

Today 01:00 am ROCHE HOLDING AG: Q1 2024 Sales and Revenue Release
Today 08:05 pm NEUREN PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
Today KINGCHEM (LIAONING) LIFE SCIENCE CO., LTD.: Q1 2024 Earnings Release
Today HANGZHOU MINSHENG HEALTHCARE CO., LTD.: Q4 2023 Earnings Release
Today NEWLAND PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today BEIJING FOYOU PHARMA CO.,LTD: Q1 2024 Earnings Release
Today PHARMABLOCK SCIENCES (NANJING), INC.: Q1 2024 Earnings Release
Today BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release (Projected)
Today GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q1 2024 Earnings Release
Today BEIJING SL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. VTRS Stock
  4. MYL Stock
  5. Calendar Mylan N.V.